en

PRODUCT DETAIL

Kandoset 16 mg/10 mg tablety

Code 3579D
MA number 58/0032/20-S
Product Form: tbl 7x1x16 mg/10 mg (blis.OPA/Al/PVC/Al-jednotliv.dáv.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 58 - HYPOTENSIVA
ATC:
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
C09DB Angiotensin II antagonists and calcium channel blockers
C09DB07 Candesartan and amlodipine
Shelf life: 24
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 07.02.2020
Validity: 07.02.2025
MA renewed: Renewal application submitted
Pediatric contraindication: Yes
PIL: PIL_Kandoset_01/2023.pdf  
SPC: SPC_Kandoset_01/2023.pdf  
Safety feature Yes
Data update: 07.02.2020
eu-flag.png sk-flag.png